PFENNIGER RICHARD C JR

Average Profitability
128.81%
Insider Buys Quantity
9
Insider Buys Sum
$367,185.65
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of PFENNIGER RICHARD C JR

According to the SEC Form 4 filings, PFENNIGER RICHARD C JR, being in a position of

  1. director at OPKO Health, Inc.,
    оver the last 12 months, has bought 25000 shares for $23,429, and sold 0 shares,
    over all time since 2019-05-13, has bought 155000 shares for $256,154, and sold 0 shares.

The largest purchase of all time was on 2019-05-13 and amounted to 50000 shares of OPKO Health, Inc. for $102,492.

Biography of PFENNIGER RICHARD C JR

No biography is available at this moment.

2024-01-05PurchaseOPKO Health, Inc.
OPK
director
25,000
0.0034%
$0.94$23,429+49.24%
2023-11-13PurchaseOPKO Health, Inc.
OPK
director
25,000
0.0033%
$1.30$32,491+5.06%
2023-11-08PurchaseGeneDx Holdings Corp.
WGS
director
10,000
0.0007%
$1.49$14,889+1,280.48%
2023-08-17PurchaseGeneDx Holdings Corp.
WGS
director
5,000
0.0012%
$5.10$25,523-1.75%
2023-05-18PurchaseGeneDx Holdings Corp.
WGS
director
5,000
0.0014%
$5.90$29,500-17.36%
2021-08-20PurchaseCocrystal Pharma, Inc.
COCP
director
40,000
0.0414%
$1.03$41,120-46.08%
2019-10-25PurchaseOPKO Health, Inc.
OPK
director
25,000
0.0042%
$1.45$36,243+49.31%
2019-05-22PurchaseOPKO Health, Inc.
OPK
director
30,000
0.0053%
$2.05$61,500-7.07%
2019-05-13PurchaseOPKO Health, Inc.
OPK
director
50,000
0.0089%
$2.05$102,492-6.12%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.